Framingham, MA, United States of America

Liqin Liu

This inventor holds 1 USPTO granted patent. Top assignee: Viacell, Inc.. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liqin Liu. Retrieved from https://idiyas.com/inventor/liqin-liu-gymit2xo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Liqin Liu - Innovator in Stem Cell Research

Introduction

Liqin Liu is a prominent inventor based in Framingham, MA, who has made significant contributions to the field of stem cell research. With a focus on modulating primary stem cell differentiation, Liu's work has the potential to impact various medical applications.

Latest Patents

Liu holds a patent titled "Modulation of primary stem cell differentiation using an insulin-like growth factor binding protein." This invention features methods for altering the endogenous activity of insulin-like growth factors to influence stem cell differentiation in culture. The patent showcases Liu's innovative approach to enhancing stem cell research.

Career Highlights

Liu is currently associated with Viacell, Inc., where he continues to explore advancements in stem cell technology. His work at Viacell has positioned him as a key player in the biotechnology sector, contributing to the development of novel therapeutic strategies.

Collaborations

Liu collaborates with notable colleagues, including Morey Kraus and Hongkui Deng. These partnerships enhance the research environment and foster innovative solutions in the field of stem cell differentiation.

Conclusion

Liqin Liu's contributions to stem cell research through his patent and work at Viacell, Inc. highlight his role as an influential inventor in the biotechnology industry. His innovative methods have the potential to advance medical science and improve therapeutic outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…